His commitment to justice and his clients' well-being is at the core of Vasquez Law Firm's mission
Comorbidities of diabetes (i.e., hypertension, dyslipidemia, obesity) also have crucial roles in pathophysiology of CKD in diabetes
On June 12, 2023, Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that new findings for efinopegdutide (MK-6024), an investigational GLP-1/glucagon receptor co-agonist, have been accepted for oral presentation at the European Association for the Study of the Liver (EASL) Annual Congress from June 21-24
It is worth mentioning that long-acting products will be more and more significant in the pulling effect of this kind of drug market, and will become mainstream drugs in the future
As discussed in our previous blog, these miracle drugs for treating obesity and type-2 diabetes are in high demand, with limited supply and only a few manufacturing companies competing for the market share
The vegan, stimulant-free positioning addresses buyer preferences that matter in this space
